PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$171.19
-2.69%
Mkt Cap $2.11B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (36 analysts)
$233.80
Range $207.00 – $270.00
Implied Upside
+36.6%
Consensus $233.80 vs current $171.19